Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Santiago Duenas Carrera
Introduction
Santiago Duenas Carrera, an inventor based in Ciudad de la Habana, Cuba, has made significant strides in the field of biotechnology. With a focus on vaccine development, his work aims to enhance immune responses against various pathogenic entities. His innovative approach emphasizes the combination of DNA and antigens to create effective vaccine formulations.
Latest Patents
Santiago holds one patent titled "Vaccine formulation potentiated by the combination of DNA and an antigen." This patent presents a formulation of vaccine antigens that incorporates several key components: a) one or more DNA sequences that express proteins in immunized individuals, and b) a viral antigen, crafted in appropriate proportions. His invention is designed to create new formulations that minimize the number of components while enhancing and diversifying the immune response. This development aims to generate combined vaccines effective against multiple pathogens, with potential applications in the pharmaceutical industry for both preventive and therapeutic use in humans.
Career Highlights
Santiago Duenas Carrera works at the Centro de Ingeniería Genética y Biotecnología, an esteemed institution dedicated to advancing genetic engineering and biotechnology. His research and innovations contribute to the ongoing efforts to combat infectious diseases through improved vaccine strategies.
Collaborations
Throughout his career, Santiago has collaborated with notable coworkers, including Juan Morales Grillo and Liz Alvarez-Lajonchere Ponce De Leon. These collaborations have enriched his research and helped push the boundaries of vaccine technology.
Conclusion
Santiago Duenas Carrera stands out as an influential figure in biotechnology and vaccine development. His innovative work continues to pave the way for advanced solutions in the fight against diseases, showcasing the importance of collaboration and creativity in scientific research.